ARTHROGENIC ALPHAVIRUS VACCINE
Vaccine comprising live attenuated recombinant alphavirus vaccine comprising mutated capsid protein
Vaccine to prevent alphavirus infections such as Chikungunya and Ross River Fever.
Vaccine - disease prevention
This invention relates to a vaccine comprising live attenuated recombinant alphavirus comprising mutated capsid protein as well as a method for preventing a subject from contracting an alphaviral infection that would otherwise produce clinical signs of disease. In an embodiment that mutated capsid protein is Chikungunya virus capsid protein having mutated nucleolar localisation signal/sequence.
Licensing
25/05/2017 00:00:00
PCT/AU2017/050489
美国